Tuberculosis in developing countries and methods for its control
- PMID: 2278088
- DOI: 10.1016/0035-9203(90)90172-b
Tuberculosis in developing countries and methods for its control
Abstract
Tuberculosis is a major cause of morbidity and mortality in developing countries. It is estimated that one-fifth of the world population is infected, 12-16 million people have the disease, every year 6-8 million develop tuberculosis and 2-3 million die from it. Four methods for the prevention of tuberculosis are available: improvement of socio-economic conditions, case-finding and treatment, chemoprophylaxis, and vaccination. Each of these methods is examined in relation to a model of the chain of transmission and development of disease. Improvement of socio-economic conditions, responsible for the decline of tuberculosis in the developed world, must be seen as a long-term solution. Case-finding and treatment is the only method expected to have an important short-term impact on transmission. A summary of the results of 35 studies shows the estimated efficacy of bacillus Calmette-Guérin (BCG) vaccination ranging from 96% to none. Follow-up results from 10 controlled trials are consistent with waning of BCG protective efficacy with time since vaccination. Chemoprophylaxis and vaccination are expected to protect the individual but not to have a significant short-term impact on transmission.
Similar articles
-
Impact of present control methods on the problem of tuberculosis.Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S360-5. doi: 10.1093/clinids/11.supplement_2.s360. Rev Infect Dis. 1989. PMID: 2652253 Review.
-
The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.Pediatrics. 1995 Jul;96(1 Pt 1):29-35. Pediatrics. 1995. PMID: 7596718
-
[Amendment of tuberculosis prevention law and prospect of tuberculosis control program].Kekkaku. 2005 Jul;80(7):541-6. Kekkaku. 2005. PMID: 16167781 Japanese.
-
Prevention of tuberculosis.Semin Respir Infect. 1989 Dec;4(4):318-25. Semin Respir Infect. 1989. PMID: 2697055 Review.
-
The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.MMWR Recomm Rep. 1996 Apr 26;45(RR-4):1-18. MMWR Recomm Rep. 1996. PMID: 8602127
Cited by
-
Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination.Clin Exp Immunol. 2001 Feb;123(2):219-25. doi: 10.1046/j.1365-2249.2001.01446.x. Clin Exp Immunol. 2001. PMID: 11207651 Free PMC article. Clinical Trial.
-
Follow up of an immunocompromised contact group of a case of open pulmonary tuberculosis on a renal unit.Thorax. 1995 Aug;50(8):863-8. doi: 10.1136/thx.50.8.863. Thorax. 1995. PMID: 7570438 Free PMC article.
-
Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco.Infect Drug Resist. 2013 Nov 28;6:207-13. doi: 10.2147/IDR.S47724. eCollection 2013. Infect Drug Resist. 2013. PMID: 24399879 Free PMC article.
-
Successful Multidisciplinary Treatment of Small Bowel Obstruction With an Ileal Stricture Resulting in Bowel Perforation in the Setting of Multidrug-Resistant Gastrointestinal Tuberculosis: A Case Report.Cureus. 2024 Jul 11;16(7):e64353. doi: 10.7759/cureus.64353. eCollection 2024 Jul. Cureus. 2024. PMID: 39007023 Free PMC article.
-
Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode.Infect Immun. 2000 Mar;68(3):1706-9. doi: 10.1128/IAI.68.3.1706-1709.2000. Infect Immun. 2000. PMID: 10678993 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical